Supplementary Methods from Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder
Authors:
- Mark SutherlandMSMark Sutherland
- Jason H. GillJGJason H. Gill
- Paul M. LoadmanPLPaul M. Loadman
- Jonathan P. LayeJLJonathan P. Laye
- Helen M. SheldrakeHSHelen M. Sheldrake
- Nicola A. IllingworthNINicola A. Illingworth
- Mohammed N. AlandasMAMohammed N. Alandas
- Patricia A. CooperPCPatricia A. Cooper
- Mark SearceyMSMark Searcey
- Klaus PorsKPKlaus Pors
- Steve D. ShnyderSSSteve D. Shnyder
- Laurence H. PattersonLPLaurence H. Patterson
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)